Localized mucosal response to intranasal live attenuated influenza vaccine in adults

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 115-124

  Barría, Maria Ines ^a   Garrido, Jose Luis ^a   Stein, Cheryl ^a   Scher, Erica ^a   Ge, Yongchao ^a   Engel, Stephanie M ^a,b   Kraus, Thomas A ^a   Banach, David ^a   Moran, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

FluMist; G CSF; Influenza; Interferon; IP10; LAIV; Vaccination

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 8; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYXOVIRUS RESISTANCE PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; STAT1 PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; COUGHING; CYTOKINE RELEASE; FEMALE; FEVER; FLU LIKE SYNDROME; GENE; GENE EXPRESSION; HUMAN; INFLAMMATION; INFLUENZA; INFLUENZA VACCINATION; INTERFERON RESPONSE GENE; MAJOR CLINICAL STUDY; MALE; MUCOSAL IMMUNITY; NOSE OBSTRUCTION; NOSE SMEAR; PRIORITY JOURNAL; RHINORRHEA; SEROCONVERSION; SORE THROAT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; COHORT STUDIES; CYTOKINES; DOGS; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84872382859     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis641     Document Type: Article

References (30)

1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96.
2. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59:1-62.
3. Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines 2004; 3:643-54.
4. Esposito S, Montinaro V, Groppali E, Tenconi R, Semino M, Principi N. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother 2012; 8:1-5.
5. Carter NJ, Curran MP. Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 2011; 71:1591-622.
6. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:S45-53.
7. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59:1-15.
8. Treanor JJ, Kotloff K, Betts RF, et al. Evaluation of trivalent, live, coldadapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999; 18:899-906.
9. Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respi Viruses 2011; 5:67-75.
10. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995; 13:1006-12.
11. Boyce TG, Gruber WC, Coleman-Dockery SD, et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18:82-8.
12. Querec TD, Akondy RS, Lee EK, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10:116-25.
13. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95.
14. FluMist [package insert] 2010. Gaithersburg, MD: MedImmune.
15. Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000; 97:43-9.
16. Kraus TA, Sperling RS, Engel SM, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol 2010; 64:411-26.
17. Murphy BR, Phelan MA, Nelson DL, et al. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol 1981; 13:554-60.
18. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95:14863-8.
19. Everitt B, Landau S, Leese M. Cluster analysis. 4th ed. New York: Oxford University Press Inc, 2001.
20. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996; 5:299-314.
21. Team RDC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2003.
22. Sasaki S, Jaimes MC, Holmes TH, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007; 81:215-28.
23. Cox NJ, Subbarao K. Influenza. Lancet 1999; 354:1277-82.
24. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, Moran TM. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 2009; 183:3569-73.
25. Cotter CR, Kim WK, Nguyen ML, et al. The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-kappaB in dendritic cells in the absence of type i interferon signaling. J Virol 2011; 85:12662-72.
26. Noah TL, Zhou H, Monaco J, Horvath K, Herbst M, Jaspers I. Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus. Environ Health Perspect 2011; 119:78-83.
27. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-9.
28. Hermesh T, Moltedo B, Moran TM, López CB. Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe 2010; 7:343-353.
29. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339:27-30.
30. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78:2791-2808.